RIMBACO (01953) announced its annual performance, with a net loss of 1.447 million ringgit, a 6.8% decrease year-on-year.

20:09 28/01/2026

RIMBACO (01953) announced its financial performance for the year ending October 31, 2025, with revenue of 260 million ringgit, a decrease of 10.1% year-on-year; net loss of 1.447 million ringgit, narrowing by 6.8% year-on-year; basic loss per share of 0.11 sen ringgit, proposing a final cash dividend of 0.027 Hong Kong dollars per share.

RIMBACO (01953) released its annual financial results for the year ending October 31, 2025, with a revenue of 260 million ringgit, a 10.1% year-on-year decrease; a net loss of 1.447 million ringgit, a 6.8% year-on-year decrease; and a basic loss per share of 0.11 sen ringgit. It is proposed to pay a final cash dividend of 0.027 Hong Kong dollars per share. The decrease in revenue for the period was mainly due to the completion of a large factory project in the 2025 financial year. The gross profit margin increased from approximately 1.4% in the 2024 financial year to approximately 5.1% in the 2025 financial year, mainly due to the completion of factory projects in the first half of 2025 and the new factory projects awarded in the 2025 financial year.

B.DUCK SEMK (02250) intends to discount approximately 9.76% to sell 67.568 million shares, raising approximately 49.5 million Hong Kong dollars.

Due to the investigation of money laundering involving employees, Deutsche Bank (DB.US) reacted before the market opened and fell sharply.

Jiahe Bioscience (06998) spent 2.4095 million Hong Kong dollars on repurchasing 973,500 shares on January 28th.

B.DUCK SEMK (02250) intends to discount approximately 9.76% to sell 67.568 million shares, raising approximately 49.5 million Hong Kong dollars.

Due to the investigation of money laundering involving employees, Deutsche Bank (DB.US) reacted before the market opened and fell sharply.

Jiahe Bioscience (06998) spent 2.4095 million Hong Kong dollars on repurchasing 973,500 shares on January 28th.